Biotronik Purchases OntoNet
/Como, July 7-th 2015. Ontonix announces that Biotronik, a leading manufacturer of cardio and endovascular medical devices, has purchased OntoNet™ for the analysis of data from monitored patients who are undergoing Cardiac Resynchronization Therapy.
About Biotronik
One of the world´s leading manufacturers of cardio and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by a global workforce of more than 5600 employees. Several million patients have received BIOTRONIK implants designed to save lives and improve quality of life. For more information on Biotronik visit website.